The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback